Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.

Subjects

Subjects :

Adenosine Monophosphate administration & dosage
Adenosine Monophosphate adverse effects
Adenosine Monophosphate analogs & derivatives
Adrenal Cortex Hormones therapeutic use
Alanine administration & dosage
Alanine adverse effects
Alanine analogs & derivatives
Amides administration & dosage
Amides adverse effects
Antibodies, Monoclonal, Humanized administration & dosage
Antibodies, Monoclonal, Humanized adverse effects
Antiviral Agents administration & dosage
Betacoronavirus drug effects
Betacoronavirus immunology
Betacoronavirus pathogenicity
COVID-19
Coronavirus Infections immunology
Coronavirus Infections virology
Cytokine Release Syndrome immunology
Cytokine Release Syndrome virology
Drug Hypersensitivity diagnosis
Drug Hypersensitivity drug therapy
Drug Hypersensitivity immunology
Humans
Immunity, Innate drug effects
Immunologic Factors administration & dosage
Indoles administration & dosage
Indoles adverse effects
Infliximab administration & dosage
Infliximab adverse effects
Interleukin 1 Receptor Antagonist Protein administration & dosage
Interleukin 1 Receptor Antagonist Protein adverse effects
Nitriles
Pandemics
Pneumonia, Viral immunology
Pneumonia, Viral virology
Pyrazines administration & dosage
Pyrazines adverse effects
Pyrazoles administration & dosage
Pyrazoles adverse effects
Pyrimidines
SARS-CoV-2
Severity of Illness Index
Antiviral Agents adverse effects
Coronavirus Infections drug therapy
Cytokine Release Syndrome prevention & control
Drug Hypersensitivity etiology
Immunologic Factors adverse effects
Pneumonia, Viral drug therapy

Details

Language :

English

ISSN :

1097-6825

Volume :

146

Issue :

4

Database :

MEDLINE

Journal :

The Journal of allergy and clinical immunology

Publication Type :

Review

Accession number :

32710973

Full Text :

https://doi.org/10.1016/j.jaci.2020.07.008